CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

A Real-world Efficacy of Nab-paclitaxel Monotherapy in Metastatic Breast Cancer

Jung Sun Kim, Koung Jin Suh, Dae-Won Lee, Go-un Woo, Miso Kim, Se Hyun Kim, Han Suk Ryu, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, So Yeon Park, In Ae Park, Jee Hyun Kim, Seock-Ah Im

Cancer Research and Treatment. 2022;54(2):488-496. Published online 2021 August 13 DOI: https://doi.org/10.4143/crt.2021.394

Real-world comparative effectiveness analysis of second-line (2L) nab-paclitaxel (nab-P) vs paclitaxel (Pac) in patients (Pts) with metastatic breast cancer (MBC)

C. Pelletier, M. Parisi, S. Glück, Q. Ni, F. Braiteh

Annals of Oncology. 2016;27:vi353

Link1 Link2 Link3

Real-world comparative effectiveness analysis of second-line (2L) nab-paclitaxel (nab-P) vs eribulin (Erib) in patients (Pts) with metastatic breast cancer (MBC)

M. Parisi, S. Glück, C. Pelletier, Q. Ni, F. Braiteh

Annals of Oncology. 2016;27:vi353

Link1 Link2 Link3

nab-Paclitaxel for the Treatment of Aggressive Metastatic Breast Cancer

Stefan Glück

Clinical Breast Cancer. 2014;14(4):221-227

Link1 Link2

A Real-world Efficacy of Nab-paclitaxel Monotherapy in Metastatic Breast Cancer

Jung Sun Kim, Koung Jin Suh, Dae-Won Lee, Go-un Woo, Miso Kim, Se Hyun Kim, Han Suk Ryu, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, So Yeon Park, In Ae Park, Jee Hyun Kim, Seock-Ah Im

Cancer Research and Treatment. 2022;54(2):488-496

Link1

Link2 Link3

Final Effectiveness and Safety Results of NABUCCO: Real-World Data From a Noninterventional, Prospective, Multicenter Study in 697 Patients With Metastatic Breast Cancer Treated With nab-Paclitaxel

Norbert Marschner, Christoph Salat, Ulrike Söling, Richard Hansen, Sina Grebhardt, Johanna Harde, Arnd Nusch, Karin Potthoff

Clinical Breast Cancer. 2018;18(6):e1323-e1337

Link1 Link2

Real-World Safety And Efficacy of Nab-Paclitaxel in Patients with Metastatic Breast Cancer (MBC) Treated in the United States: Results From a Health Insurance Database

D. Patt, C. Liang, L. Li, A. Ko, C. Duval Fraser, D. Corzo, C. Enger

Value in Health. 2014;17(3):A70-A71

Link1 Link2

Comparative effectiveness of early-line <em>nab</em>-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis

Reshma L Mahtani, Monika Parisi, Stefan Glück, Quanhong Ni, Siyeon Park, Corey Pelletier, Claudio Faria, Fadi Braiteh

Cancer Management and Research. 2018;Volume 10:249-256

Link1 Link2

251 Retrospective Analysis of the Relative Efficacy and Toxicity of Nab-paclitaxel and Docetaxel in Metastatic Breast Cancer

S.J. Howell, A.C. Armstrong, L. Ashcroft

European Journal of Cancer. 2012;48:S115-S116

Link1 Link2

Nanoparticle albumin-bound (nab™)-paclitaxel: improving efficacy and tolerability by targeted drug delivery in metastatic breast cancer

Javier Cortes, Cristina Saura

European Journal of Cancer Supplements. 2010;8(1):1-10

Link1 Link2

Real-World Efficacy of Fulvestrant Monotherapy as the First Treatment or Maintenance Treatment in Patients with Metastatic Breast Cancer

Meng Lv, Yan Mao, Teng Ma, Yongmei Wang, Xiaoyi Liu, Yuhua Song, Haibo Wang

Breast Care. 2020;16(4):368-375

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.